Answers are grounded in this paper and cite their sources.
Evaluates biological activity of vinyloxy ethoxy-substituted zinc phthalocyanines, indicating potential therapeutic applications.
Phthalocyanines, whose various derivatives can be synthesized and designed, serve as an effective source for the discovery of new therapeutic agents. Supporting their biological properties will play a decisive role in the active use of these compounds. Firstly, 4‐(2‐(vinyloxy)ethoxy)phthalonitrile ( 3 ) and [tetrakis‐(2‐(vinyloxy)ethoxy)phthalocyaninato]zinc(II) ( 4 ) compounds were synthesized and characterized. Then, investigations were conducted into the biological activity of compounds 3 and 4 . According to the data, 4 had good antioxidant activity (66.54% ± 3.57%) and 3 had outstanding antidiabetic activity (97.19% ± 4.96%). Whereas 4 showed one‐strand cleavage activity at 62.5 mg/L and fully cleaved DNA at 250 mg/L, 3 exhibited complete cleavage ability on DNA at all concentrations. Both compounds showed antimicrobial activity, but 3 (MICs ranging from 8 to 64 mg/L) was more effective against pathogenic microorganisms than compound 4 (MICs ranging from 32 to 128 mg/L). With photodynamic therapy, the biofilm inhibition activity of 3 against Staphylococcus aureus increased from 86.66% ± 4.58% to 97.12% ± 4.98%, and that of 4 increased from 81.65% ± 4.26% to 90.57% ± 4.74%. The biofilm inhibition activity against Pseudomonas aeruginosa increased from 94.13% ± 4.94% to 100% ± 5.62% for 3 and from 89.53% ± 4.76% to 97.81% ± 5.18% for 4 . Furthermore, at 25 mg/L, both compounds showed a 100% ± 5.69% inhibition of microbial cell viability. According to the study's findings, 3 and 4 may both be developed further as medicinal treatments, especially photodynamic therapy.
No takes yet. Share an insight, caveat, or question.
Turan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: